General
TGA chief says investigations likely to reveal more details about ‘atypical’ blood-clotting death
The head of the Therapeutic Goods Administration says an autopsy and review may reveal further information about a woman’s death from blood clotting likely linked to the AstraZeneca vaccine.
Key points:
- Professor Skerritt said the woman’s death was an “atypical” case
- The TGA said on Friday the fatal blood clotting was likely linked to the AstraZeneca vaccine
- The federal government is asking health authorities to continuously review all vaccines in the wake of the death
The 48-year-old woman from the New South Wales Central Coast had underlying health conditions but died in hospital several days after receiving the vaccine.
She received the AstraZeneca vaccine before authorities changed their advice to say people aged under 50 should…
-
Noosa News13 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General12 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
Noosa News16 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
Noosa News20 hours agoManjimup engineer turns previously wasted avocados into liquid gold